China Product Registration, Test Protocol Reforms Targeted By AdvaMed
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed is drafting a case study on the regulation of pacemakers in China as a way to pinpoint potential hurdles for U.S. manufacturers